Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

F Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for the Delivery of Adaptive Radiation Therapy

NCT01908504 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT01908504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01908504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
F Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for the Delivery of Adaptive Radiation Therapy
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
September 30, 2016
Enrollment
271 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal, cervix, vulvar, vaginal, and endometrium cancers, head and neck cancers, lung and esophagus cancers